Enliven Therapeutics, Inc. (ELVN) vs Nurix Therapeutics, Inc. (NRIX)
- Enliven Therapeutics, Inc. ELVN 37.32 −5.11%
- Nurix Therapeutics, Inc. NRIX 24.42 −2.12%
Enliven Therapeutics, Inc. and Nurix Therapeutics, Inc. are both Biotechnology companies. Enliven Therapeutics, Inc. and Nurix Therapeutics, Inc. are of similar size ($2.9B and $2.7B). Enliven Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 9.7×. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Nurix Therapeutics, Inc. leads on 9 and Enliven Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ELVN | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 41.27% | 0.00% |
| Net margin | 0.00% | 42.01% | 0.00% |
| Free cash flow margin | 0.00% | 52.68% | 0.00% |
| Return on equity | (15.31%) | 43.99% | (56.36%) |
| Return on assets | (14.98%) | 34.33% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack